According to Reuters, according to Reuters, according to Reuters, according to the data of Johns Hopkins University, countries with corresponding financial resources have stockpiled 51% of what is currently considered the most promising coronavirus vaccine.
As a result, about 25% of the world’s population is likely to be unable to be vaccinated against the novel coronavirus by 2022.
According to reports, U.S. expert data show that countries with corresponding financial resources have now stockpiled 51% of what is currently considered the most promising coronavirus vaccine.
Of these, the governments of Australia, Canada and Japan have ordered more than 1 billion doses, but these countries account for less than 1% of the confirmed cases worldwide.
At the same time, countries with poor financial resources can only divide the remaining vaccines, while these countries account for 85% of the global population.
Johns Hopkins experts have concluded that even if leading pharmaceutical companies can reach planned production capacity, about 25% of the world’s population will still not be able to complete vaccination by the end of 2021.
Experts also pointed out that the “COVID-19 Vaccine Implementation Plan” (COVAX) established by WHO may become a key mechanism to ensure more equitable access to the coronavirus vaccine, but only 500 million doses of vaccine are currently purchased under the framework of the mechanism, while 2 billion doses are planned to be purchased by the end of 2021.